Projects

Objectives: 1/ Develop rationally designed ‘FMT-in-a-pill’ oral formulations with enhanced effect on CC prevention/treatment. • 2/ Evaluate the effect of ‘oral’ vs. the traditional ‘gastroduodenal tube’ administration of FMTs in the context of CC. • 3/ Make significant progresses on the development of oral ‘consortium-in-a-pill’ formulations for CC treatment.